Grünenthal uses its own and third-party cookies to improve the browsing experience, offer personalized content and improve its services. We use analytics scripts which set tracking cookie, but we will activate these services only with your consent. If you press the button “Accept”, you consent to the use of these analytics scripts.

You can withdraw your consent at any time. To do so, please modify your configurations on this website by following this link to our privacy statement with the configuration options:
Go to settings

Accept

;

Grünenthal Clinical Trial Portal

As a research-based pharmaceutical company, Grünenthal recognizes the importance of publicly registering clinical trials and making information including results available. Please consult the table below to easily find information on Grünenthal sponsored clinical trials.

Number Product Condition Brief Title Column Phase Status Results
No
KF10004/01 5% Lidocaine medicated plaster Postherpetic neuralgia 3 Completed No
KF10004/02 5% Lidocaine medicated plaster Postherpetic neuralgia 3 Completed No
KF10004/10 5% Lidocaine medicated plaster Localized chronic post-operative neuropathic pain -- 3 Completed Yes
EN3324-201 Axomadol Moderate to severe chronic low back pain -- 2 Completed No
HP0151Y/09 Axomadol -- A Clinical Study in Healthy Subjects Which Aims to Investigate the Safety, the Tolerability and the Effects of GRT0151Y and How the Compound is Taken up and Excreted From the Body 1 Completed No
HP0151Y/10 Axomadol -- A Clinical Study in Healthy Adults Who Sometimes Take Drugs for Pleasure to Investigate the Safety and Tolerability of GRT0151Y and to Find Out Which Single Dose of the Compound is Maximally Tolerated 1 Completed No
HP0151Y/13 Axomadol -- A Clinical Study in Healthy Adults Who Sometimes Take Drugs for Pleasure Which Aims to Evaluate Whether GRT0151Y is Likely to be Abused 1 Completed No
KF0151Y/06 Axomadol Postoperative pain following tonsillectomy -- 2 Completed Yes
KF0151Y/07 Axomadol Chronic knee-joint osteoarthritis -- 2 Completed Yes